Abstract
Kasabach-Merritt syndrome is a rare disorder of the newborn or very young child which combines a rapidly expanding red-purple vascular tumor and a hematological syndrome dominated by major thrombocytopenia and more moderate consumption of fibrinogen and coagulation. This syndrome is always considered serious due to hemorrhages related to coagulopathy. Imaging confirms the diagnosis and searches for deep locations. Therapeutic management must be early, multidisciplinary, adapting the benefits to therapeutic risks in order to improve the prognosis. We report the case of a KASABACH-MERRITT Syndrome on a preexisting thigh angioma triggered by vaccination in a female infant treated with angiogenesis SIROLIMUS, to focus on the cause and effect relationship between vaccination and SKM in the light of literature.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: International Journal of Scientific Research and Management
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
